23 May 2013
Keywords: astrazeneca, abbott, laboratories, develop, combination, cholesterol, drug
Article | 17 July 2006
Anglo-Swedish drug major AstraZeneca and US health care major Abbott Laboratories say they will collaborate on the development of a
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 July 2006
22 May 2013
© 2013 thepharmaletter.com